Search results for "uno"

showing 10 items of 14944 documents

Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin

2017

Candida albicans is a dimorphic commensal fungus that causes severe oral infections in immunodeficient patients. Invasion of C. albicans hyphae into oral epithelium is an essential virulence trait. Interleukin-17 (IL-17) signaling is required for both innate and adaptive immunity to C. albicans. During the innate response, IL-17 is produced by γδ T cells and a poorly understood population of innate-acting CD4+ αβ T cell receptor (TCRαβ)+ cells, but only the TCRαβ+ cells expand during acute infection. Confirming the innate nature of these cells, the TCR was not detectably activated during the primary response, as evidenced by Nur77eGFP mice that report antigen-specific signaling through the …

0301 basic medicineInnate immune systembiologyVirulence FactorsImmunologyPattern recognition receptorEpithelial CellsInflammationGeneral Medicinebiology.organism_classificationAcquired immune systemArticleCorpus albicansMicrobiologyFungal Proteins03 medical and health sciences030104 developmental biology0302 clinical medicineImmunityCandida albicansmedicinemedicine.symptomCandida albicansCandidalysin030215 immunologyScience Immunology
researchProduct

2018

The catabolic process of autophagy plays important functions in inflammatory and immune responses by modulating innate immunity and adaptive immunity. Over the last decade, a cell-intrinsic role for autophagy in modulating CD4 T cell functions and differentiation was revealed. After the initial observation of autophagosomes in effector CD4 T cells, further work has shown that not only autophagy levels are modulated in CD4 T cells in response to environmental signals but also that autophagy critically affects the biology of these cells. Mouse models of autophagy deletion in CD4 T cells have indeed shown that autophagy is essential for CD4 T cell survival and homeostasis in peripheral lymphoi…

0301 basic medicineInnate immune systemmedicine.medical_treatmentT cellImmunologyCellAutophagyImmunotherapyBiologyAcquired immune systemT-Cell Receptor Activation3. Good healthCell biology03 medical and health sciences030104 developmental biologymedicine.anatomical_structureImmune systemmedicineImmunology and AllergyFrontiers in Immunology
researchProduct

Allergen-Specific Low Zone Tolerance Is Independent of MRP8/14-, TLR4-, TLR7-, and TLR9-Mediated Immune Processes.

2017

0301 basic medicineInnate immunologyDermatologymedicine.disease_causeDermatitis ContactBiochemistry03 medical and health sciencesMiceAllergenImmune systemImmunitymedicineImmune ToleranceAnimalsCalgranulin BHumansCalgranulin AMolecular BiologySkinMice KnockoutToll-like receptorMembrane Glycoproteinsbusiness.industryTLR9Cell BiologyTLR7Immunity InnateToll-Like Receptor 4Disease Models Animal030104 developmental biologyToll-Like Receptor 7Toll-Like Receptor 9ImmunologyTLR4businessHaptensSignal TransductionThe Journal of investigative dermatology
researchProduct

Increased survival of honeybees in the laboratory after simultaneous exposure to low doses of pesticides and bacteria

2018

Recent studies of honeybees and bumblebees have examined combinatory effects of different stressors, as insect pollinators are naturally exposed to multiple stressors. At the same time the potential influences of simultaneously occurring agricultural agents on insect pollinator health remain largely unknown. Due to different farming methods, and the drift of applied agents and manure, pollinators are most probably exposed to insecticides but also bacteria from organic fertilizers at the same time. We orally exposed honeybee workers to sub-lethal doses of the insecticide thiacloprid and two strains of the bacterium Enterococcus faecalis, which can occur in manure from farming animals. Our re…

0301 basic medicineInsecticidesmehiläisetPollinationPhysiologyThiazineslcsh:MedicineInsect010501 environmental sciencesPathology and Laboratory Medicine01 natural sciencesimmune responseCALORIC RESTRICTIONbakteeritToxicologyAPIS-MELLIFERA Lchemistry.chemical_compoundEatingNeonicotinoidsPollinatorMedicine and Health Scienceslcsh:SciencePollinationtarhamehiläinenbacteriaDIETARY RESTRICTIONmedia_common2. Zero hungerMultidisciplinarybiologyVirulenceEukaryotaAgricultureBeesThiaclopridBacterial PathogensInsectsBEE HYMENOPTERA APIDAEMedical Microbiologyimmuunivaste1181 Ecology evolutionary biologyRISK-ASSESSMENTPathogensHoney BeesAgrochemicalshenkiinjääminenResearch ArticlehoneybeesArthropodamedia_common.quotation_subjectImmunologyENTEROCOCCUS-FAECALISEnterococcus FaecalisMicrobiologysurvivalNEONICOTINOID INSECTICIDES03 medical and health sciencesHormesisStress PhysiologicalAnimalsFORAGING BEHAVIORLEARNING PERFORMANCESMicrobial Pathogens0105 earth and related environmental sciencesNutritionlcsh:RHormesisOrganismsFood ConsumptionBiology and Life Sciencestorjunta-aineetpesticidesPesticidebiology.organism_classificationManureInvertebratesHymenopteraDiet030104 developmental biologychemistryDROSOPHILA-MELANOGASTERta1181lcsh:QPest ControlPhysiological ProcessesBacteriaEnterococcus
researchProduct

An essential role for the IL-2 receptor in Treg cell function

2016

Regulatory T cells (Treg cells), which have abundant expression of the interleukin 2 receptor (IL-2R), are reliant on IL-2 produced by activated T cells. This feature indicates a key role for a simple network based on the consumption of IL-2 by Treg cells in their suppressor function. However, congenital deficiency in IL-2R results in reduced expression of the Treg cell lineage-specification factor Foxp3, which has confounded experimental efforts to understand the role of IL-2R expression and signaling in the suppressor function of Treg cells. Using genetic gain- and loss-of-function approaches, we found that capture of IL-2 was dispensable for the control of CD4+ T cells but was important …

0301 basic medicineInterleukin 2ImmunologyFOXP3Immune receptorBiologyImmune toleranceCell biology03 medical and health sciences030104 developmental biology0302 clinical medicineImmunologymedicineImmunology and AllergyIL-2 receptorReceptorTranscription factorCD8030215 immunologymedicine.drugNature Immunology
researchProduct

Interleukin-2 Functionalized Nanocapsules for T Cell-Based Immunotherapy.

2016

A major demand on immunotherapy is the direct interference with specific immune cells in vivo. In contrast to antibody-engineered nanoparticles to control dendritic cells function, targeting of T cells for biomedical applications still remains an obstacle as they disclose reduced endocytic activities. Here, by coupling the cytokine interleukin-2 (IL-2) to the surface of hydroxyethyl starch nanocapsules, we demonstrated a direct and specifc T cell targeting in vitro and in vivo by IL-2 receptor-mediated internalization. For this purpose, defined amounts of azide-functionalized IL-2 were linked to alkyne-functionalized hydroxyethyl starch nanocapsules via copper-free click reactions. In combi…

0301 basic medicineInterleukin 2Materials sciencemedicine.medical_treatmentT cellmedia_common.quotation_subjectGeneral Physics and Astronomy02 engineering and technologyNanocapsules03 medical and health sciencesImmune systemIn vivomedicineGeneral Materials ScienceInternalizationmedia_commonGeneral EngineeringImmunotherapy021001 nanoscience & nanotechnologyCell biology030104 developmental biologyCytokinemedicine.anatomical_structureImmunology0210 nano-technologymedicine.drug
researchProduct

Targeted Activation of T Cells with IL-2-Coupled Nanoparticles

2020

Interleukin-2 (IL-2) is a T cell growth factor particularly required in regulatory T cell maintenance and memory T cell responses. High-dose IL-2 treatment was the first FDA-approved immunotherapy for cancer, while low-dose IL-2 administration has shown promise in allograft rejection and autoimmune and inflammatory diseases. However, its pleiotropic nature and the existence of IL-2 receptors with different binding affinity limit its therapeutic application. For an improved clinical applicability of the cytokine, a targeted receptor assignment must, therefore, be achieved. Nanoparticles allow controlling the location and dose of immunomodulating compounds and to specifically address specific…

0301 basic medicineInterleukin 2Regulatory T cellT-Lymphocytesmedicine.medical_treatmentT cellReviewmedicine.disease_causeAutoimmunity03 medical and health sciences0302 clinical medicinemedicineHumansReceptorlcsh:QH301-705.5General MedicineImmunotherapy030104 developmental biologymedicine.anatomical_structureCytokinelcsh:Biology (General)030220 oncology & carcinogenesisCancer researchinterleukin-2nanoparticlesimmunotherapyMemory T cellmedicine.drugCells
researchProduct

Editorial: The Molecular Mechanisms of Cyclic AMP in Regulation of Immunity and Tolerance

2017

0301 basic medicineInterleukin 2conventional CD4+ T cellsImmunologyBiologymedicine.diseaseinducible cAMP early repressornaturally occurring regulatory CD4+CD25+ T cells03 medical and health sciencesEditorial030104 developmental biology0302 clinical medicineGraft-versus-host diseaseImmunityINDUCIBLE cAMP EARLY REPRESSORImmunologymedicinegraft-versus-host diseaseImmunology and Allergycyclic AMPinterleukin-2CD28-responsive element030215 immunologymedicine.drugFrontiers in Immunology
researchProduct

Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion

2015

Activation of TNFR2 with a novel agonist expands T reg cells in vivo and protects allo-HCT recipients from acute GvHD while sparing antilymphoma and antiinfectious properties of transplanted donor T cells.

0301 basic medicineInterleukin 2medicine.medical_treatmentImmunologyGraft vs Host DiseaseMice Inbred Strainschemical and pharmacologic phenomenaHematopoietic stem cell transplantationBiologyT-Lymphocytes RegulatoryArticleMice03 medical and health sciencesInterleukin 21immune system diseaseshemic and lymphatic diseasesmedicineAnimalsReceptors Tumor Necrosis Factor Type IIImmunology and AllergyCytotoxic T cellddc:610Research Articlesintegumentary systemMyeloid-Derived Suppressor CellsHematopoietic Stem Cell TransplantationFOXP3hemic and immune systemsmedicine.diseaseLeukemiaddc:57030104 developmental biologysurgical procedures operativeAcute DiseaseImmunologyMyeloid-derived Suppressor CellInterleukin-2FemaleTumor necrosis factor receptor 2medicine.drug
researchProduct

The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes

2018

Background Although in the past, prevention of the joint destruction and disability was strongly emphasised in Rheumatoid Arthritis (RA), at present, a growing body of evidence is focused at identifying the best management of associated comorbidities, such as Type 2 Diabetes (T2D). Recently, the hypothesis that blocking pro-inflammatory activity may be helpful in the treatment of some comorbidities has been proposed in RA patients. Objective We reviewed the role of IL-1β during RA and T2D, the efficacy of IL-1 blocking agents in controlling both diseases and, possible, decreasing the concomitant enhanced atherosclerotic process. Method After literature search, the available evidence has bee…

0301 basic medicineInterleukin-1betaInflammationAnakinra; Cardiovascular risk; Diabetes; IL-1β; Pathogenesis; Rheumatoid arthritis; Therapy; PharmacologyType 2 diabetesPathogenesisDiabeteProinflammatory cytokinePathogenesisArthritis Rheumatoid03 medical and health sciencesImmune systemPathogenesiDiabetes mellitusmedicineHumansRheumatoid arthritisRheumatoid arthritiPharmacologyAnakinrabusiness.industryDiabetesAntirheumatic AgentReceptors Interleukin-1General Medicinemedicine.diseaseCardiovascular riskSettore MED/16 - Reumatologia030104 developmental biologyAnakinraDiabetes Mellitus Type 2IL-1βRheumatoid arthritisAntirheumatic AgentsImmunologyTherapymedicine.symptombusinessmedicine.drugHuman
researchProduct